US 8,795,693 B2  Page 13  (56)  References Cited  OTHER PUBLICATIONS  Ebadi et al., "Healing effect of topical nifedipine on skin wounds of  diabetic rats,"  DARU,  2003, 11(1):19-22.  Effendy and Maibach. "Surfactants and Experimental Irritant Con› tact Dermatitis."  Contact Dermatol.,  1995, 33:217-225.  Elias and Ghadially, "The aged epidermal permeability barrier,"  Clinical Geriatric Medicine,  Feb. 2002, pp. 103-120.  Fantin et al., "Critical influence of resistance to streptogramin B-type  antibiotics on activity of RP 59500 (Quinupristin-dalfopristin) in  experimental  endocarditis  due  to  Staphylococcus  aureus,"  Antimicrob Agents and Chemothery,  1999, 39:400-405.  Fluhr et al., "Glycerol accelerates recovery of barrier function in  vivo,"  Acta Derm. Venereal,.  1999, 79:418-21.  Garti et al. "Sucrose Esters microemulsions,"  J Malec. Liquids,  1999, 80:253-296.  Hammer et al. "Anti-Microbial Activity of Essential Oils and other  Plant extracts,"  J Applied Microbiology,  1999, 86:985-990.  Hwang et al. "Isolation and identification of mosquito repellents in  Artemisia vulgaris," J Chem. Ecol.,  11: 1297-1306, 1985.  Knight et al., "Topical diltiazem ointment in the treatment of chronic  anal fissure,"  Br. J Surg.,  2001, 88(4):553-6.  Kucharekova et al., "Effect of a lipid-rich emollient containing  ceramide 3 in experimentally induced skin barrier dysfunction,"  Con› tact Dermatitis,  Jun. 2002, pp. 331-338.  Leive et al, "Tetracyclines of various hydrophobicities as a probe for  permeability of  Escherichia coli  outer membrane,"  Antimicrobial  Agents and Chemotherapy,  1984, 25:539-544.  Luepke and Kemper, "The HET-CAM Test: An Alternative to the  Draize Eye Test,"  FD Chem,. Toxic.,  1986, 24:495-196.  Osborne and Henke, "Skin Penetration Enhancers Cited in the Tech› nical Literature,"  Pharm. Technology,  Nov. 1997, pp. 58-86.  Padi. "Minocycline prevents the development of neuropathic pain,  but not acute pain: possible anti-inflammatory and antioxidant  mechanisms,"  Eur J Pharmacol,  2008, 601 :79-87.  Palamaras and Kyriakis, "Calcium antagonists in dermatology: a  review of the evidence and research-based studies,"  Derm. Online  Journal,  2005, 11(2):8.  Passi et al., Lipophilic antioxidants in human sebum and aging,  Free  Radical Research,  2002, pp. 471-477.  Perrotti et al., "Topical Nifedipine With Lidocaine Ointment vs.  Active Control for Treatment of Chronic Anal Fissure,"  Dis Colon  Rectum,  2002, 45(11): 1468-1475.  Repa et al. "All-trans-retinol is a ligand for the retinoic acid recep› tors,"  Proc. Natl. Acad Sci, USA,  90: 7293-7297, 1993.  Ruledge, "Some corrections to the record on insect repellents and  attractants,"  J Am. Mosquito Control Assoc,  1988, 4(4): 414-425.  Sakai et al., "Characterization of the physical properties of the stra› tum corneum by a new tactile sensor,"  Skin Research and Technology,  Aug. 2000, pp. 128-134.  Schaefer, "Silicone Surfactants,"  Tenside, Surfactants, Deterg.,  1990,  27(3): 154-158.  Simoni et al., "Retinoic acid and analogs as potent inducers of dif› ferentiation and apoptosis. New promising chemopreventive and  chemotherapeutic agents in oncology,"  Pure Appl Chem.,  2001,  73(9): 1437-1444.  Smith, "Hydroxy acids and skin again,"  Soap Cosmetics Chemical  Specialties,  1993, pp. 54-59.  Solans et al. "Overview of basic aspects ofmicroemulsions," Indus› trial Applications of Microemulsions, Solans et al Eds, New York,  1997, 66:1-17.  Squillante et al., "Codiffusion of propylene glycol and dimethyl  isosorbide in hairless mouse skin,"  European J Pharm. Biopharm.,  1998, 46(3):265-71.  Todd et al. "Volatile Silicone Fluids for Cosmetics,"  91 Cosmetics  and Toiletries,  1976, 27-32.  Torma et al.,  "Biologic activities of retinoic acid and 3,  4-dehydroretinoic acid in human keratinoacytes are similar and cor› relate with receptor affinities and transactivation properties,"  J  invest. Dermatology,  1994, 102: 49-54.  "Human Immunodeficiency Virus Infection," Merch Manual Home  Edition, 2008, retrieved on Jan. 16, 2013, <http://www.merckmanu› als.com/home/infections/human_immunodeficiency _ virus_hiv _  "HLB Systems", http:/ /pharmcal.tripod.corn/chl 7.htm, Accessed  Sep.17, 2010, pp.1-3.  "Gas Gangrene," Merch Manual Home Edition, 2008, retrieved on  Jan. 16, 2013, <http://www.merckmanuals.com/home/infections/  bacterial_infections/gas_gangrene.html?qt~gasgangrene  &alt~sh> 1 page.  "Fully refined paraffin waxes (FRP Wax),"  Industrial Raw Materials  LLC,  Feb. 21, 2008, retrieved on Aug. 22, 2013, <http:/ /irmwax.corn/  Wax/Paraffin/fully _refined.asp> 1 page.  "Drug Index (Professional)-Dacarbazine,"  BC Cancer Agency,  Jun.  2004, retrieved on Oct. 18, 2013, <URL:http://www.bccancer.bc.ca/  HPI/DrugDatabase/DrugindexPro/Dacarbazine.htm>, 6 pages.  "Dacarbazine,"  Chemical Book,  2010, retrieved on Oct. 18, 2013,  <URL: http://www.chemicalbook.com/ChemicalProductProperty_  EN_CB7710656.htm>, 2 pages.  "Crohn’s Disease,"  Merch Manual Home Edition,  retrieved on Jan.  16, 2013, <http://www.merckmanuals.com/home/digestive_disor› ders/inflammatory _bowel_diseases_ibd/crohn_disease.  html?qt~crohn’s disease&alt~sh>, 3 pages.  "Burn patients need vitamin D supplements."  Decision News Media,  Jan. 23, 2004, http://www.nutraingredients.com/Research/Burn-pa› tients-need-vitamin-D-supplements, Accessed: May 5, 2010.  "Can tuberous sclerosis be prevented?,"  Sharecare,  2002, retrieved  on Aug.  29,  2013,  <URL:  http://www.sharecare.com/health/  autosomal-dominant-genetic-disorders/can-tuberous-sclerosis-be› prevented;j sessionid~850 579B605 20A907DE7 5930E06 l E60E6>,  2 pages.  "Arquad HTL8-MS,"  AkzoNobel Functional Applications,  retrieved  on Mar. 18, 2013, Retrieved from the Internet: <URL: http://sc.  akzono be! .corn/ en/fa/Pages/product -detail .aspx?prodID~87 64>,  1  page.  International Preliminary Report on Patentability from PCT /IB2007 /  004628, dated Jun. 3, 2009, 6 pages; International Search Report,  dated May 6, 2009, 4 pages.  "Tea tree oil," Chemical Abstract No. 68647-73-4, 2012, 2 pages.  Lin et al., "Ferulic acid stabilizes a solution of vitamins c and e and  doubles its protoprotection of skin,"  J invest Dermatol,  2005,  125:826-32.  "Mineral oil USP," Chemical Abstracts Service Registry No. 8012- 95-1, 2011, 7 pages.  Cloez-Tayarani. et al., "Differential effect of serotonin on cytokine  production in lipopolysaccharide-stimulatedhuman peripheral blood  mononuclear cells: involvement of 5-hydroxytryptamine2A recep› tors,"  lnt. lmmunol.,  2003, 15:233-40.  Brown et al. "Structural dependence of flavonoid interactions with  Cu2+ inos: implications for their antioxidant properties,"  Biochem.  J,  1998, 330:1173-1178.  Tzen et al., Lipids, proteins and structure of seed oil bodies from  diverse species;  Plant Physiol.,  1993, 101:267-276.  Paragraph E.3.1 of regulation (EC) No. 2003 (See Directive 67/548/  EEC  OJ  196, 16.8, 1967, p. 1.  Yamada et al., "Candesartan, an angiotensin II receptor antagonist,  suppresses pancreatic inflammation and fibrosis in rats,"  J  Pharmacol. Exp. Ther.,  2003, 307(1)17-23.  Xynos et al., "Effect ofnifedipine on rectoanal motility,"  Dis Colon  Rectum,  1996, 39(2):212-216.  Wang and Chen, "Preparation and surface active properties of bio› degradable dextrin derivative surfactants,"  Colloids and Surfaces A:  Physicochemical and Engineering Aspects,  2006, 281( 1-3): 190-193.  Weindl et al., "Hyaluronic acid in the treatment and prevention of  skin diseases: molecular biological, pharmaceutical and clinical  aspects,"  Skin Pharmacology and Physiology,  2004, 17: 207-213.  Van Cutsem et al., "The antiinflammatory efects ofketoconazole,"  J  Am. Acad. Dermatol.,1991,  25(2 pt 1):257-261.  Van Slyke, "On the measurement of buffer values and on the rela› tionship of buffer value to the dissociation constant of the buffer and  the concentration and reaction of the buffer solution,"  J Biol. Chem.,  1922, 52:525-570.  USP23/NF 18 The United States Pharmacopeia: The National For› mulary, US Pharmacopoeia, 1995, p. 10-14. 